- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-05-0050407

Ambito Pharma Private Limited
About Ambito Pharma Private Limited
Data last updated:
Ambito Pharma Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 15 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U85300UR2018PTC008551. Its GSTIN is 05AAQCA6617G1ZL (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Monika Badoni and Geeta Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 B Arvind Marg, Dehradun, Uttarakhand, India – 248001.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.98 Lakh, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹74,383 (net margin 3.5%) and EBITDA of ₹99,113 (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years.
Ambito Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0050407).
Company details
Recognitions & Rankings of Ambito Pharma
Contact details
Ambito Pharma Private Limited's registered office is in Dehradun, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered Address8 B Arvind Marg, Dehradun, Uttarakhand, India – 248001
- IndustryNon-Profit Organizations, Social Work
To see the full contact details of Ambito Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ambito Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ambito Pharma Private Limited, buy the company report.
Financials of Ambito Pharma Private Limited
FY 2025 filings availableAmbito Pharma Private Limited reported revenue of ₹20.98 Lakh (up 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over three years, including 48% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹99,113 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹74,383 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ambito Pharma Private Limited, buy the company report.
Board of directors of Ambito Pharma Private Limited
Ambito Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monika Badoni | Director | 28 Dec 2020 | 5 Years 10 Months | Current |
| Geeta Kumar | Director | 28 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Ambito Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Paradigm One Exports Private Limited | ₹20.99 Lakh (FY 2016) | 104.0% | Noida, Uttar Pradesh, India | |||
| Pratesh Traders Private Limited | ₹20.99 Lakh (FY 2023) | 11.0% | Begusarai, Bihar, India | |||
| Contrivance IT Solutions Private Limited | ₹20.99 Lakh (FY 2018) | 40.0% | Jaipur, Rajasthan, India | |||
| Nathbaba Agro Tradehub Private Limited | ₹20.99 Lakh (FY 2021) | Pune, Maharashtra, India | ||||
| DGH Healthcare Private Limited | ₹20.99 Lakh (FY 2023) | 417.0% | Pune, Maharashtra, India | |||
| Ambito Pharma Private Limitedthis company | ₹20.98 Lakh (FY 2025) | ₹74,383 | 3.5% | 48.0% | Dehradun, Uttarakhand, India | |
| Made in Swadeshi International Trade & Venture Private Limited | ₹20.98 Lakh (FY 2025) | -47.0% | Nashik, Maharashtra, India | |||
| S C Wires Private Limited | ₹20.98 Lakh (FY 2025) | -37.0% | Delhi, India | |||
| King Penguin Exim Private Limited | ₹20.98 Lakh (FY 2025) | 3.0% | Churu, Rajasthan, India | |||
| C S Pasodi Production and Manufacturing Industries (OPC) Private Limited | ₹20.98 Lakh (FY 2023) | 13.0% | Raichur, Karnataka, India | |||
| Gopal Hosiery Pvt Ltd | ₹20.98 Lakh (FY 2025) | 12.0% | West Bengal, India |
To see the full peer comparison of Ambito Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ambito Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ambito Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ambito Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAQCA6617G1ZL | Uttarakhand | Active | 22 Jan 2021 |
To see the full GST registrations and return filing status of Ambito Pharma Private Limited, buy the company report.
Recent activity
Ambito Pharma Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Nitin Kumar ceased to be Director on 30 Dec 2020.
Frequently asked questions
Ambito Pharma is an active private limited company based in Dehradun, Uttarakhand, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 15 March 2018 (8+ years old) and is registered under CIN U85300UR2018PTC008551.
Ambito Pharma has 2 current directors:
- Monika Badoni - Director
- Geeta Kumar - Director
The latest financial statements of Ambito Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ambito Pharma is 05AAQCA6617G1ZL, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Ambito Pharma is U85300UR2018PTC008551. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ambito Pharma was incorporated on 15 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Ambito Pharma by revenue are Paradigm One Exports Private Limited, Pratesh Traders Private Limited, Contrivance IT Solutions Private Limited, Nathbaba Agro Tradehub Private Limited, DGH Healthcare Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Nitin Kumar ceased to be Director on 30 Dec 2020. Sanchit Kumar ceased to be Director on 30 Dec 2020. Geeta Kumar was appointed as Director on 28 Dec 2020. Ambito Pharma has 4 board changes on record in total.
Yes, Ambito Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-05-0050407).
The registered office of Ambito Pharma is at 8 B Arvind Marg, Dehradun, Uttarakhand, India – 248001.
Ambito Pharma operates in the non-profit organizations industry, in the social work segment.

